Slide A Vision for a
Life Sciences & Biotechnology Strategy
READ MORE EUROPABIO MANIFESTO Unleashing the full potential of Life Sciences and Biotechnology in Europe
February 24, 2021

European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback

February 15, 2021

The Business of Biotechnology: Growing for Europe’s tomorrow

February 12, 2021

EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion

February 12, 2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

February 2, 2021

Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)

January 29, 2021

Building a European Health Union

January 28, 2021

European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation

January 20, 2021

Revision of the EU legislation on medicines for children and rare diseases

November 30, 2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms

November 25, 2020

EuropaBio Statement on the EU Pharmaceutical Strategy

November 2, 2020

EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association

October 20, 2020

EU ATMP Hospital Exemption

October 20, 2020

EuropaBio on Use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making

October 19, 2020

Application of the ATMP Hospital Exemption in the EU

October 2, 2020

#EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference

September 30, 2020

EuropaBio Patient engagement with the European Medicines Agency

September 3, 2020

Novartis’s Andrew Topen appointed as new Chairman of EuropaBio

August 13, 2020

Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations

August 3, 2020

Joint Statement on the Health Innovation Partnership Proposal

July 30, 2020

Joint response of EuropaBio and BIO on the EU Data Strategy Consultation

July 30, 2020

EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy

July 30, 2020

EuropaBio response to the Work Programme of the eHealth Stakeholder Group

July 15, 2020

EuropaBio position paper on the Farm to Fork Strategy

June 30, 2020

EuropaBio observations in response to Europe’s Beating Cancer Plan

 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe

FOLLOW US HERE


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


facebook
twitter
instagram
linkedin
youtube
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
February 15, 2021

The Business of Biotechnology: Growing for Europe’s tomorrow

Read EuropaBio Report ‘Measuring the Economic Footprint of the Biotechnology Industry in Europe’
January 28, 2021

European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation

Read the European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation.
November 25, 2020

EuropaBio Statement on the EU Pharmaceutical Strategy

EuropaBio looks forward to working closely with the European institutions to ensure the Pharmaceutical Strategy delivers for European patients and establishes a framework that enables a successful life sciences sector for the medium to long-term.
November 2, 2020

EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association

EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association.
October 2, 2020

#EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference

As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy.
September 3, 2020

Novartis’s Andrew Topen appointed as new Chairman of EuropaBio

Novartis’s Andrew Topen appointed as new Chairman of EuropaBio.
May 20, 2020

EuropaBio highlights synergies between biotechnology and Farm to Fork and Biodiversity Strategy ambitions

EuropaBio's reaction on the publication of the Farm to Form and Biodiversity Strategies of the European Commission.
October 10, 2019

Wealth of innovation on display & bio-based winners revealed at EFIB 2019 in Brussels

The John Sime Award for the best innovation presentation delivered at EFIB 2019 was granted to Guillaume Daoulas, Head of Strategic Marketing at Ÿnsect. In the exhibition, a new area was featuring 20 academic posters. The prize of the best academic poster was awarded to Thomas Gassler from the University of Natural Resources and Life Sciences, Vienna.
September 30, 2019

#EFIB2019 – EuropaBio hosts 12th annual Industrial Biotech and Bioeconomy Conference

As the new European Institutions draw up political guidelines and goals to address climate and sustainability challenges, this year’s conference will highlight the sector’s latest achievements and the potential of a circular bioeconomy for Europe.
February 20, 2019

Export Manufacturing Waiver for Supplementary Protection Certificates: a red flag for investment in EU healthcare biotech

As the Association representing the European biotechnology industry, EuropaBio is fully committed to the development of a legislative environment which facilitates the creation of EU jobs and growth as well as new solutions to healthcare challenges.
December 20, 2018

Case Studies demonstrating Industrial Biotech contribution to UN SDGs

As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy.
October 16, 2018

#EFIB2018 – Toulouse hosts 11th edition of leading Industrial Biotech Conference highlighting the breakthroughs and potential of the circular bioeconomy

Speakers will call for Europe to continue their commitment to building a sustainable, circular bioeconomy.
October 11, 2018

EuropaBio welcomes renewed commitment to the EU Bioeconomy

EuropaBio is pleased to welcome the publication of an updated EU Bioeconomy Strategy.
May 28, 2018

SPC waiver risks downgrading the EU as a hub for Health Innovation

As an association that has manufacturers of both originator and biosimilar medicines as members, EuropaBio strongly doubts that the promises of today’s Commission proposal outweigh the risks of losing investment in new medicines.
May 25, 2018

EFIB 2018 Registrations are now open

Opening of the registrations for the 11th edition of EFIB, the European Forum for Industrial Biotechnology and the Bioeconomy.
Become a member